- Paper Report
- Open Access
Simple new method to accelerate clearance of carbon monoxide
- Jonathan Ball1
© Current Science Ltd 2000
- Published: 30 June 2000
- Carbon monoxide poisoning
- respiratory therapy
CO inhalation is the leading cause of fatal poisoning in the industrialised world. Current therapy consists of either the administration of 100% oxygen, or, where available, hyperbaric oxygen. Inhaled carbon dioxide (CO2) (5%) therapy as an adjunct to oxygen was advocated in the 1920s but fell from routine use due to its poor tolerability. Similarly, hyperpnea, despite enhancing CO elimination, provokes a respiratory alkalosis with consequent aggravation of already impaired cerebral oxygen delivery. Fisher and colleagues have previously demonstrated the efficacy of a novel breathing circuit in dogs which provokes normocapnic hyperoxic hyperpnea producing a > 50% reduction in CO half life. This study investigated the efficacy of the same method in healthy human volunteers.
A randomised crossover trial design seven male healthy volunteers
Volunteers were connected to non-rebreathing circuit. The inspiratory side of the circuit consisted of a water spirometer and a fresh gas supply
Following a baseline period in which room air was inspired and minute volume measured, CO was administered until a blood level of 10-12% carboxyhaemoglobin (COHb) was achieved
Subjects were randomised to receive either, 100% O2 resting minute volume maintained or, a CO2/O2 oxygen mixture and set a minute volume of between two and six times their resting minute volume, with the carbon dioxide concentration set to maintain their arterial PaCO2 within 3 mmHg of their resting level
The protocol was repeated the following day, with subjects receiving the treatment they hadn't had the previous day
COHb levels were monitored in order to establish the elimination kinetics associated with the two methods
After 60 min COHb levels decreased from 10.6 ± 0.4% to 6.2 ± 1.1% in subjects breathing 100% oxygen, and from 11.0 ± 0.9% to 3.0 ± 1.0% duringnormocapnic hyperoxic hyperpnea. A surrogate measure of myocardial oxygenconsumption did not change throughout. All subjects maintained hyperpneafor 90 min without difficulty.